Search for a command to run...
Ben Lamm discusses Colossal Biosciences' groundbreaking work in de-extinction, focusing on bringing back dire wolves through genetic engineering and highlighting the potential for conservation, scientific advancement, and inspiring future generations.
Jake Becraft describes how Strand Therapeutics is developing programmable mRNA technology to create targeted cancer treatments that activate the immune system to selectively attack tumor cells, potentially transforming cancer from a fatal disease to a manageable condition.
In this special GTC edition podcast episode, scientists and technology leaders explore how AI is transforming scientific discovery, accelerating research across fields from drug development to quantum computing, and potentially revolutionizing our understanding of molecular design, human biology, and complex systems.
A deep dive into the groundbreaking gene therapy treatment of baby KJ, who was born with a rare genetic disorder, highlighting the potential of personalized genetic editing to treat previously untreatable conditions.
Cathy Tie, a young biotech entrepreneur, discusses her new startup Manhattan Project, which aims to use gene editing on embryos to eliminate genetic diseases. In a wide-ranging conversation, she explores the ethical, scientific, and personal dimensions of germline gene editing, challenging conservative biotech norms and advocating for responsible technological advancement.